SALVARAGEN Trademark

Trademark Overview


On Wednesday, April 4, 2012, a trademark application was filed for SALVARAGEN with the United States Patent and Trademark Office. The USPTO has given the SALVARAGEN trademark a serial number of 85589572. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 13, 2013. This trademark is owned by Salvaragen, Inc.. The SALVARAGEN trademark is filed in the Pharmaceutical Products category with the following description:

Ferments for pharmaceutical purposes; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
salvaragen

General Information


Serial Number85589572
Word MarkSALVARAGEN
Filing DateWednesday, April 4, 2012
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 13, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesFerments for pharmaceutical purposes; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 13, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSalvaragen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10005

Trademark Events


Event DateEvent Description
Monday, May 13, 2013ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, May 13, 2013ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, October 11, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 11, 2012FINAL REFUSAL E-MAILED
Thursday, October 11, 2012FINAL REFUSAL WRITTEN
Thursday, September 20, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 20, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 11, 2012ASSIGNED TO LIE
Wednesday, September 5, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 17, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 17, 2012NON-FINAL ACTION E-MAILED
Tuesday, July 17, 2012NON-FINAL ACTION WRITTEN
Tuesday, July 17, 2012ASSIGNED TO EXAMINER
Friday, April 13, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 7, 2012NEW APPLICATION ENTERED IN TRAM